PatientsLikeMe | pharmaphorum

Skip to main content

Monday 23 December 2024

twitter linkedin facebook rss

User account menu

Subscribe

Channels

Content type

Categories

Categories

Sort by

Order

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

close

Channels

Content type

Categories

Categories

Sort by

Order

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

Sign up

twitter linkedin facebook rss

Sign in

PatientsLikeMe

News

PatientsLikeMe

UnitedHealth buys PatientsLikeMe after Trump intervention

The US health services giant UnitedHealth Group has bought PatientsLikeMe, which had been forced to find a buyer by the Trump administration because of its links with China.

News

trump_kentucky

China-US feud forces PatientsLikeMe to find new investor - p...

Increasingly fraught Sino-American relations are beginning to have a real impact on the health sector, after it emerged that the health networking startup PatientsLikeMe is being forced to

News

PatientsLikeMe

PatientsLikeMe and Shire to co-develop rare disease patient ...

Data from the new platform will help inform rare disease drug development.

Articles

PatientsLikeMe

AstraZeneca, Genentech fund PatientsLikeMe research into can...

PatientsLikeMe is working with AstraZeneca and Roche to find about more about the experiences of people being treated for lung cancer

Editor's Picks

Novo completes $16.5bn takeover of Catalent

UnitedHealth killing suspect gets first-degree murder charge

Novo sets aside $1.2bn for rare diseases plant

Lilly's Alzheimer's drug Kisunla is cleared in China

PBM reform looms in end-of-year US legislation package

News

US Congress

PBM reform dropped in Congress' funding package

Proposed reforms to the regulations for PBMs were dropped from the US Congress' end-of-year bill to provide funding to the federal government.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

The AI effect in pharma commercial strategy: From data to real-time insight & actions

Sponsored

The AI effect in pharma commercial strategy: From data to re...

Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Subscribe

rss facebook linkedin twitter

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company